Facilitation of immunoreactive corticotropin-releasing factor secretion into the hypophysial-portal circulation after activation of catecholaminergic pathways or central norepinephrine injection.
about
Hindbrain noradrenergic A2 neurons: diverse roles in autonomic, endocrine, cognitive, and behavioral functionsInvolvement of noradrenergic transmission in the PVN on CREB activation, TORC1 levels, and pituitary-adrenal axis activity during morphine withdrawalNegative Energy Balance Blocks Neural and Behavioral Responses to Acute Stress by "Silencing" Central Glucagon-Like Peptide 1 Signaling in RatsRestraint stress-induced reduction in prepulse inhibition in Brown Norway rats: role of the CRF2 receptorDifferent stress-related phenotypes of BALB/c mice from in-house or vendor: alterations of the sympathetic and HPA axis responsiveness.Mother to infant or infant to mother? Reciprocal regulation of responsiveness to stress in rodents and the implications for humansNeonatal handling induces anovulatory estrous cycles in rats.Brain activation patterns at exhaustion in rats that differ in inherent exercise capacity.Interleukin 1 prevents loss of corticotropic responsiveness to beta-adrenergic stimulation in vitro.Influence of steroids on the hypothalamic corticotropin-releasing factor and preproenkephalin mRNA responses to stress.Studies of the secretion of corticotropin-releasing factor and arginine vasopressin into the hypophysial-portal circulation of the conscious sheep. II. The central noradrenergic and neuropeptide Y pathways cause immediate and prolonged hypothalamic-Role of glucocorticoids in tuning hindbrain stress integrationCentral noradrenergic mechanisms underlying acute stress responses of the Hypothalamo-pituitary-adrenal axis: adaptations through pregnancy and lactation.Chronic pain, chronic stress and depression: coincidence or consequence?Multiple feedback regulatory loops upon rat hypothalamic corticotropin-releasing hormone secretion. Potential clinical implications.Catecholamine effects upon rat hypothalamic corticotropin-releasing hormone secretion in vitro.The anxiogenic drug yohimbine reinstates palatable food seeking in a rat relapse model: a role of CRF1 receptors.The role of the hypothalamic-pituitary-adrenal axis in neuroendocrine responses to stressGlucocorticoid actions on synapses, circuits, and behavior: implications for the energetics of stress.Long-term antidepressant administration alters corticotropin-releasing hormone, tyrosine hydroxylase, and mineralocorticoid receptor gene expression in rat brain. Therapeutic implications.Role of nucleus of the solitary tract noradrenergic neurons in post-stress cardiovascular and hormonal control in male rats.Neuroendocrinology of nutritional infertility.Chronic stress-induced neurotransmitter plasticity in the PVN.Role of nitric oxide in interleukin 2-induced corticotropin-releasing factor release from incubated hypothalami.Measuring the activity of brain adrenergic receptors in man.Visceral sensory inputs to the endocrine hypothalamus.Chronic intermittent hypoxia sensitizes acute hypothalamic-pituitary-adrenal stress reactivity and Fos induction in the rat locus coeruleus in response to subsequent immobilization stress.Elevated glucocorticoid levels are responsible for induction of tyrosine hydroxylase mRNA expression, phosphorylation, and enzyme activity in the nucleus of the solitary tract during morphine withdrawalModulation of stress by imidazoline binding sites: implications for psychiatric disorders.Central neuroregulation of hypothalamic corticotropin-releasing hormone (CRH-41) secretion.Stress: Neurobiology, consequences and management.Sex differences in the HPA axis.Neural Regulation of the Stress Response: The Many Faces of Feedback.Hypothalamic adrenergic receptor changes in the metabolic syndrome of genetically obese (ob/ob) mice.Genetic, Epigenetic, and Environmental Factors Influencing Neurovisceral Integration of Cardiovascular Modulation: Focus on Multiple Sclerosis.Impaired Neurovisceral Integration of Cardiovascular Modulation Contributes to Multiple Sclerosis Morbidities.Ascending mechanisms of stress integration: Implications for brainstem regulation of neuroendocrine and behavioral stress responses.Adolescence and the ontogeny of the hormonal stress response in male and female rats and mice.Interoceptive modulation of neuroendocrine, emotional, and hypophagic responses to stress.Atomoxetine increases salivary cortisol in healthy volunteers.
P2860
Q28296208-2AF5E132-179D-4E77-A6F5-8C5AE9A7E355Q28480798-FE025D1F-7F63-4D55-945F-E135608A1439Q30392753-2647C6B7-5D79-49BF-9B25-6ECD77BF93A9Q30470071-32D67D07-C8E5-45C5-BAFD-22065E571414Q30482504-9E56708E-BB9C-4E16-A621-FA49B1491EC3Q30500810-F63A0BA2-67CE-4E5E-8634-689B6C83B1E7Q30785379-5050F541-244A-40A1-8F81-3D952B979569Q31101601-A0FE182B-34D1-44E0-9CFB-CA9F272E621EQ33635687-1AB2DC6E-D3D1-4539-9784-D9636393ECA7Q33868419-B5E0713A-6EEA-4BC8-ABF7-1C0C1FD0676CQ34138015-C606C6E3-AA41-42C4-B6E3-D299C719A37BQ34382571-A09F37A0-73CE-405D-9567-7252B2E12F18Q34434031-B2459051-C49C-4EFF-B4EC-C81B07BC150BQ34448514-CF15F45C-C4F8-4953-BFBE-AEA658B88F92Q34555737-057C46D0-5CB4-48F8-AB5E-334D50DCAF51Q34561818-0BFE6831-1245-4514-9B56-B5B2E9C386B9Q35039457-068B0AFC-6043-4C0E-B336-C29B3BD3DF90Q35236877-112E9FA3-5810-45BF-AD72-64112121BDE1Q35575671-4FA6276D-2943-4F17-A27C-D2EC7D3201F2Q35819190-F300819E-E169-4477-B9CC-4033A3B1786EQ35855374-EC044ABF-4582-4E1A-AE7D-95CF95C70E15Q35940430-77D31B26-1168-48A8-9CE9-3BFF6A35CD18Q35962936-DE9F0941-3299-4306-A8EA-4665621FF629Q36241458-28BBF40C-D87C-416C-80A2-603E79297A79Q36402577-FA020C26-996A-4C31-916B-EF1D5A742821Q36773058-0FE2E1A1-2F9A-427D-90F1-695C4F72815BQ36849018-9D65388A-577E-4E19-B99B-154B4C21BE1AQ37244714-F15BA89A-3B24-41B0-96FF-7B48E2A1D266Q37324414-B65842BF-ABE4-4007-B826-9C4A4EC0FB6EQ37610990-E56D36AB-A1B2-447C-9455-0F3E27F8D63DQ38119947-938BA642-E379-46C3-8C8D-CC123B484FA0Q38221452-0FD11428-4352-48D8-8550-E15138A4D22AQ38301563-C800AFA6-3298-41EF-9416-357E14C6374CQ38309530-547399F1-27DA-4BDC-965B-C4B359F47FF6Q38616570-C58B6985-82E9-4022-8C8A-59D6ACEC6F97Q38689611-BC357762-3A3F-4B92-A674-589C67558EEBQ38840579-BEFE31CA-55DB-4E79-BBA9-0445BE06D043Q38846601-F2BEF5CB-11B8-48EF-884F-B872439B14AFQ39092040-FD7DD9CB-E8E8-490B-904D-7E196211E9B5Q40221613-DD433CE8-A314-4E15-B776-1ED0B431CE79
P2860
Facilitation of immunoreactive corticotropin-releasing factor secretion into the hypophysial-portal circulation after activation of catecholaminergic pathways or central norepinephrine injection.
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
1987年论文
@zh
1987年论文
@zh-cn
name
Facilitation of immunoreactive ...... tral norepinephrine injection.
@en
Facilitation of immunoreactive ...... tral norepinephrine injection.
@nl
type
label
Facilitation of immunoreactive ...... tral norepinephrine injection.
@en
Facilitation of immunoreactive ...... tral norepinephrine injection.
@nl
prefLabel
Facilitation of immunoreactive ...... tral norepinephrine injection.
@en
Facilitation of immunoreactive ...... tral norepinephrine injection.
@nl
P356
P1433
P1476
Facilitation of immunoreactive ...... tral norepinephrine injection.
@en
P2093
Plotsky PM
P304
P356
10.1210/ENDO-121-3-924
P407
P577
1987-09-01T00:00:00Z